/PRNewswire/ Silicon Valley Bank, the bank of the world s most innovative companies and investors, and Hercules Capital, Inc. (NYSE: HTGC), today announced.
- Non-dilutive financing facility, plus $312M existing cash on hand as of June 30, 2022, gives atai access to up to $487M to continue developing next generation mental health treatments -. | August 15, 2022
Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics announced that its existing term loan facility agreement with Hercules Capital has been amended to increase the size of the facility to $200 million, with $70 million funded at closing. Michael S. Weiss, Chairman and Chief Executive Officer of TG Therapeutics stated, “We are pleased to announce the expansion of our term loan.